AGP Picks
View all

European Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Ledger.

Press releases published on October 26, 2026

Seismic Therapeutic to Participate in Upcoming Investor Conferences
Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
PC Parts UK Launches Specialist Online Store With Over 4,000 Components for Builders and Upgraders
New Temporary Insurance Website, Temp Insurance UK, Launches for UK Motorists
Adial Pharmaceuticals Announces Planned Appointment of Celia Economides as Chief Financial Officer
NevGold Appoints Sean Waller to Board of Directors; Key Addition of Project Development and Mineral Process Engineering Expertise
HI-VIEW IP SURVEY IDENTIFIES MULTIPLE POTENTIAL PORPHYRY TARGETS AT THE BLACK PEARL, TOODOGGONE REGION, BRITISH COLUMBIA
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Convening
Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP
Maxus Mining Engages Understood Mineral Resources to Advance Resource-Focused Work at Quarry Project
All NIOB Bardy Holes Hit Meaningful TREO Grades in at Least One Interval
MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
TILT Biotherapeutics Presents Encouraging Phase 1b Results in Ovarian Cancer at ESMO 2026
VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
Goldera Identifies Large Gold-Tungsten-Antimony Anomaly at Riley Brook, with Multiple Targets Remaining Open
BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.